Drug recall · June 30, 2021
Diflorasone Diacetate Ointment USP recall
Why: Presence of Foreign Substance: Foreign particles observed during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Diflorasone Diacetate Ointment USP, 0.05%, packaged in a)15 g (NDC 52565-063-15) and b) 30 g (NDC 52565-063-30) tubes, Rx only, Manufactured by: Teligent Pharma, Inc, Buena, NJ 08310.
- Lots / codes
Lot #: 16264, Exp Date Nov 2022
- Quantity
- 6,240 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Nationwide in the United States
- Initiated
- May 14, 2021 · Voluntary: Firm initiated
- Classified
- June 23, 2021
- Reported
- June 30, 2021
- Ended
- August 22, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diflorasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.